Silence Therapeutics Plc ADR (SLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 559 | 43,258 | 31,643 | 21,647 | 17,072 |
| Cost of Goods | 215 | 11,810 | 12,867 | 13,458 | 10,253 |
| Gross Profit | 344 | 31,448 | 18,776 | 8,190 | 6,819 |
| Operating Expenses | 91,636 | 95,577 | 84,026 | 68,752 | 70,071 |
| Operating Income | -91,077 | -63,319 | -64,383 | -60,105 | -62,999 |
| Interest Expense | 0 | 0 | 0 | 58 | 72 |
| Other Income | 2,476 | 18,855 | 11,111 | 1,573 | 14 |
| Pre-tax Income | -88,601 | -44,464 | -53,272 | -58,590 | -63,057 |
| Income Tax | 11 | 845 | 956 | -8,509 | -8,864 |
| Net Income Continuous | -88,612 | -45,309 | -54,228 | -50,081 | -54,193 |
| Net Income | $-88,612 | $-45,309 | $-54,228 | $-50,081 | $-54,193 |
| EPS Basic Total Ops | -1.88 | -0.98 | -1.46 | -1.55 | -1.83 |
| EPS Basic Continuous Ops | -1.88 | -0.98 | -1.46 | -1.56 | -1.83 |
| EPS Diluted Total Ops | -1.88 | -0.98 | -1.46 | -1.55 | -1.83 |
| EPS Diluted Continuous Ops | -1.88 | -0.98 | -1.46 | -1.56 | -1.83 |
| EPS Diluted Before Non-Recurring Items | -1.86 | -0.99 | -1.45 | -1.56 | -1.83 |
| EBITDA(a) | $-90,522 | $-62,726 | $-63,762 | $-59,509 | $-62,412 |